Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008

Biomarkers

Volumn 16, Issue 2, 2011, Pages 112-119

  Xia, Yang ^a   Bernert, John T ^a   Jain, Ram B ^a   Ashley, David L ^b   Pirkle, James L ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b CENTER FOR TOBACCO PRODUCTS   (United States)

Author keywords

4 (methylnitrosamino) 1 (3 pyridyl) 1 butanone; NHANES; NNAL; NNK; smoking; tobacco; TSNA

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; COTININE; CREATININE; MENTHOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CIGARETTE SMOKING; CREATININE URINE LEVEL; ETHNIC DIFFERENCE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; RACE DIFFERENCE; SCHOOL CHILD; SEX DIFFERENCE; SMOKING; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BIOLOGICAL MARKERS; CARCINOGENS; COTININE; CREATININE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; NITROSAMINES; NUTRITION SURVEYS; PYRIDINES; SMOKING; TARS; TOBACCO; UNITED STATES; YOUNG ADULT;

NICOTIANA TABACUM;

EID: 79951913809     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.533288     Document Type: Article

References (47)

1. American Cancer Society. (2009). Cancer Facts & Figures 2009, page 46. Available at: http://www.cancer.org/acs/groups/content/@ nho/documents/document/500809webpdf.pdf. Accessed on 14 September, 2010.
2. Andersen RA, Kemp TR. (1985). Accumulation of 4-(N-methyl-Nnitrosamino)- 1-(3-pyridyl)-1-butanone in alkaloid genotypes of burley tobacco during postharvest processing: comparisons with N'-nitrosonornicotine and probable nitrosamine precursors. Cancer Res 45:5287-5293. (Pubitemid 16200834)
3. Ashley DL, O'Connor RJ, Bernert JT, Watson CH, Polzin GM, Jain RB, Hammond D, Hatsukami DK, Giovino GA, Cummings KM, McNeill A, Shahab L, King B, Fong GT, Zhang L, Xia Y, Yan X, and McCraw JM. (2010). Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers. Cancer Epidemiol Biomark Prev 19:1389-1398.
4. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. (2005). Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113:192-200. (Pubitemid 40326330)
5. Benowitz NL, Jacob P, Bernert JT, Wilson M, Wang L, Allen F, Dempsey D. (2005). Carcinogen exposure during short-term switching from regular to "light" cigarettes. Cancer Epidemiol Biomark Prev 14:1376-1383. (Pubitemid 40807334)
6. Bernert JT, Jain RB, Pirkle JL, Wang L, Miller BB, Sampson EJ. (2005). Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes. Nicotine Tob Res 7:729-738. (Pubitemid 41700974)
7. Bernert JT, Pirkle JL, Xia Y, Jain RB, Ashley DL, Sampson EJ. (2010). Urine Concentrations of a Tobacco-Specific Nitrosamine Carcinogen in the U.S. Population from Second hand Smoke Exposure. Cancer Epidemiol Biomark Prev doi:10.1158/1055- 9965.EPI-10-0711
8. Caraballo RS, Giovino GA, Pechacek TF, Mowery PD, Richter PA, Strauss WJ, Sharp DJ, Erisksen MP, Pirkle JL, Maurer KR. (1998). Racial and ethnic differences in serum cotinine levels of cigarette smokers. Third National Health and Nutrition Examination Survey, 1988-1991. J Am Med Assoc 280:135-139. (Pubitemid 28498384)
9. Carmella SG, Akerkar S, Hecht SS. (1993). Metabolites of the tobaccospecific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone in smokers' urine. Cancer Res 53:721-724. (Pubitemid 23077849)
10. Carmella SG, Akerkar SA, Richie JP Jr, Hecht SS. (1995). Intraindividual and interindividual differences in metabolites of the tobaccospecific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1 -butanone (NNK) in smokers' urine. Cancer Epidemiol Biomark Prev 4:635-642.
11. Carmella SG, Le K, Upadhyaya P, Hecht SS. (2002) Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Chem Res Toxicol 15:545-550. (Pubitemid 34326937)
12. Carmella SG, Han S, Fristad A, Yang Y, Hecht SS. (2003). Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Cancer Epidemiol Biomark Prev 12:1257-1261. (Pubitemid 37499454)
13. Caudill SP, Schleicher RL, Pirkle JL. (2008). Multi-rule quality control for the age-related eye disease study. Stat Med 27:4094-4106.
14. Centers for Disease Control and Prevention. (1994). Surveillance for Selected Tobacco-Use Behaviors - United States, 1900-1994. Morbidity and Mortality Weekly Report, 43, SS-3.
15. Centers for Disease Control,and Prevention. (2009). Cigarette smoking among adults and trends in smoking cessation - United States, 2008. Morbidity and Mortality Weekly Report, 58, 1227-1232.
16. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey 2007-2008. Available at: http:// www.cdc.gov/nchs/nhanes. htm. Accessed on 4 March, 2010.
17. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey, Note on 2007-2008 Sampling Methodology. Available at: http://www.cdc.gov/nchs/nhanes/ nhanes2007-2008/sampling-0708.htm. Accessed on 4 March, 2010.
18. Chen F, Cole P, Bina W. (2007). Time trend and geographic patterns of lung adenocarcinoma in the United States, 1973-2002. Cancer Epidemiol Biomarkers Prev 16:2724-2729. (Pubitemid 351210549)
19. Hatsukami DK, Benowitz NL, Rennard SI, Oncken C, Hecht SS. (2006). Biomarkers to assess the utility of potential reduced exposure products. Nicotine Tob Res 4:600-622.
20. Hecht SS, Hoffmann D. (1988). Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 9:875-884.
21. Hecht SS. (1999). Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91:1194-1210. (Pubitemid 29357186)
22. Hecht SS. (1998). Biochemistry, biology, and carcinogenicity of tobacco- specific N-nitrosamines. Chem Res Toxicol 11:559-603.
23. Hecht SS. (2002). Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 23:907-922. (Pubitemid 34752946)
24. Hecht SS, Murphy SE, Carmella SG, Li S, Jensen J, Le C, Joseph AM, Hatsukami DK. (2005). Similar uptake of lung carcinogens by smokers of regular, light and ultralight cigarettes. Cancer Epidemiol Biomark Prev 14:693-698. (Pubitemid 40489216)
25. Hecht SS, Carmella SG, Murphy SE, Riley WT, Le C, Luo X, Mooney M, Hatuskami DK. (2007). Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiol Biomark Prev 16:1567-1572. (Pubitemid 47294820)
26. Heck JD. (2009). Smokers of menthol and nonmenthol cigarette exhibit similar levels of biomarkers of smoke exposure. Cancer Epidemiol Biomark Prev 18:622-629.
27. Hoffmann D, Hoffmann I. (1997). The changing cigarette, 1950-1995. J Toxicol Environ Health 50:307-364.
28. IARC. (1986). Tobacco smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France, Volume 38.
29. IARC. (2004). Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Lyon, France, Volume 83.
30. IARC. (2007). Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Lyon, France, Volume 89.
31. Institute of Medicine. Clearing the Smoke: the Science Base for Tobacco Harm Reduction. (2001). In: Stratton, K., Sheety, P., Wallace, R., & Bondurant, S., editors. Surveillence for the health and behavioral consequences of exposure reduction. Washington, DC, National Academy Press, 190.
32. Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. (2008). Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 393:535-545.
33. Liang PS, Chen TY, Giovannucci E. (2009). Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer 124: 2406-2415.
34. Muscat JE, Djordjevic MV, Colosimo S, Stellman SD, Richie JP. (2005). Racial differences in exposure and glucuronidation of the tobacco- specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone (NNK). Cancer 103:1420-1426. (Pubitemid 40410738)
35. Perez-Stable EJ, Herrera B, Jacob P, Benowitz NL. (1998). Nicotine metabolism and intake in black and white smokers. J Am Med Assoc 280:152-156. (Pubitemid 28498387)
36. Peterson LA, Ng DK, Stearns RA, Hecht SS. (1994). Formation of NADP(H) analogs of tobacco-specific nitrosamines in rat liver and pancreatic microsomes. Chem Res Toxicol 7: 599-608. (Pubitemid 24302154)
37. Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR. (1996). Exposure of the U.S. population to environmental tobacco smoke. The third National Health and Nutrition Evaluation Survey, 1988- 1991. J Am Med Assoc 275:1233-1240. (Pubitemid 26118496)
38. Pleis JR, Lucas JW, Ward BW. (2009). Summary health statistics for U.S. adults: National Health Interview Survey, 2008. National Center for Health Statistics. Vital Health Stat 10(242).
39. Preston-Martin S. (1987). N-nitroso compounds as a cause of human cancer. IARC Sci Publ 84:477-484.
40. Richie JP Jr, Carmella SG, Muscat JE, Scott DG, Akerkar SA, Hecht SS. (1997). Differences in the urinary metabolites of the tobaccospecific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone in black and white smokers. Cancer Epidemiol Biomark Prev 6:783-790. (Pubitemid 27435476)
41. Roethig HJ, Munjal S, Feng S, Liang Q, Sarkar M, Walk R, Mendes P. (2009). Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers. Nicotine Tob Res 11:1216-1225.
42. Smith CJ, Perfetti TA, Garg R, Hansch C. (2003). IARC carcinogens reported in cigarette mainstream smoke and their calculated log P values. Food Chem Toxicol 41:807-817. (Pubitemid 36555886)
43. United States. Department of Health and Human Services. (2003). The NSDUH (National Survey on Drug Use and Health) Report, Quantity and frequency of cigarette use. Available at: http:// www.oas.samhsa.gov/2k3/cigs/cigs.htm. Accessed on 22 June, 2009.
44. United States Department of Health and Human Services. (2004). The health consequences of smoking: a report of the Surgeon General. Centers for Disease Control and Prevention. Atlanta, GA.
45. World Health Organization. (1997). Tobacco or health: a global status report. World Health Organization. Geneva.
46. Xia Y, McGuffey JE, Bhattacharyya S, Sellergren B, Yilmaz E, Wang L, Bernert JT. (2005). Analysis of the Tobacco-specific Nitrosamine 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol in Urine by Extraction on a Molecularly Imprinted Polymer Column and Liquid Chromatography/Atmospheric Pressure Ionization Tandem Mass Spectrometry. Anal Chem 77:7639-7645. (Pubitemid 41746231)
47. Xia Y, Bernert JT. (2010). Stability of the Tobacco-Specific Nitrosamine 4-(Methylnitros & ino)-1-(3-pyridyl)-1-butanol (NNAL) in Urine Samples Stored at Various Temperatures. J Anal Toxicol 34:411-415.